首页> 中文期刊> 《中华医学杂志(英文版)》 >Performance of Fasting Plasma Glucose and Postprandial Urine Glucose in Screening for Diabetes in Chinese High-risk Population

Performance of Fasting Plasma Glucose and Postprandial Urine Glucose in Screening for Diabetes in Chinese High-risk Population

         

摘要

Background: The conventional approaches to diabetes screening are potentially limited by poor compliance and laboratory demand.This study aimed to evaluate the performance of fasting plasma glucose (FPG) and postprandial urine glucose (PUG) in screening for diabetes in Chinese high-risk population.Methods: Nine hundred and nine subjects with high-risk factors of diabetes underwent oral glucose tolerance test after an overnight fast.FPG, hemoglobin A 1 c, 2-h plasma glucose (2 h-PG), and 2 h-PUG were evaluated.Diabetes and prediabetes were defined by the American Diabetes Association criteria.The area under the receiver operating characteristic (ROC) curve was used to evaluate the diagnostic accuracy of 2 h-PUG, and the optimal cut-offdetermined to provide the largest Youden index.Spearman correlation was used for relationship analysis.Results: Among 909 subjects, 33.4% (304/909) of subjects had prediabetes, and 17.2% (156/909) had diabetes.The 2 h-PUG was positively related to FPG and 2 h-PG (r =0.428 and 0.551, respectively, both P < 0.001).For estimation of 2 h-PG ≥ 7.8 mmol/L and 2 h-PG ≥ 1 1.1 mmol/L using 2 h-PUG, the area under the ROC curve were 0.772 (95% confidence interval [CI]: 0.738-0.806) and 0.885 (95% CI:0.850~.921), respectively.The corresponding optimal cut-offs for 2 h-PUG were 5.6 mmol/L and 7.5 mmol/L, respectively.Compared with FPG alone, FPG combined with 2 h-PUG had a higher sensitivity for detecting glucose abnormalities (84.1% vs.73.7%, P < 0.001) and diabetes (82.7% vs.48.1%, P < 0.001).Conclusion: FPG combined with 2 h-PUG substantially improves the sensitivity in detecting prediabetes and diabetes relative to FPG alone, and may represent an efficient layperson-oriented diabetes screening method.

著录项

  • 来源
    《中华医学杂志(英文版)》 |2015年第24期|3270-3275|共6页
  • 作者单位

    Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China;

    Hi-Tech Research Institute of Nanjing Tech University, Nanjing, Jiangsu 210009, China;

    Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China;

    Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China;

    Discipline of Medicine and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, SA 5005, Australia;

    Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China;

    Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China;

    Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号